What Chaplains Should Know About Psychedelic Medicines

In this webinar, our guests offered a presentation for chaplains on psychedelic medicines, with a particular focus on psychedelics' potential application for end of life and palliative care (EOLPC) patients. Chaplains served as study clinicians in a recent clinical trial of psilocybin therapy at UCSF, and chaplains are now being included in more trials with EOLPC populations both at Dana-Farber Cancer Institute and Emory Healthcare. This presentation looks toward a future of greater openness to, and recognition of the benefits of, working with chaplains as the field of psychedelic medicine continues to grow.[/vc_column_text][/vc_column][/vc_row . . .

This content is only available to subscribers to the Chaplaincy Innovation Lab. 

Most archived webinars are restricted to users at the Innovator level.

You can become a Subscriber, or upgrade to Innovator, right here! You may also login if you already have an account.